SATVN 'Automation: Defining the Future of ATMP and Vaccine Manufacturing'

In partnership with IBioIC, the Scottish Advanced Therapies and Vaccines Network are hosting an evening of talks, lively discussion, and networking.

The event will focus on the examination of the tools in Advanced Therapy Medicinal Product (ATMP) manufacturing and will explore the opportunities and challenges these technologies bring for ATMP manufacturers through a mixture of talks and panel discussions, which will be followed by a networking reception.

Tom Smith, Labman’s Head of Bioprocess Automation is delighted to be joining the panel session, ‘Exploring the potential for automation and digitalisation to optimise vaccine and ATMP manufacturing processes’ alongside Martin Keane, Digital Innovation Manager, CPI, Neil McGowan, Eligible Qualified Person, Adthera, and Bill Shingleton, Director of R&D – Cell Therapy, Cytiva.